2018
DOI: 10.3389/fvets.2018.00116
|View full text |Cite
|
Sign up to set email alerts
|

Oncolytic Sendai Virus Therapy of Canine Mast Cell Tumors (A Pilot Study)

Abstract: Background: Canine mastocytomas (mast cell tumors) represent a common malignancy among many dog breeds. A typical treatment strategy for canine mastocytomas includes surgery, chemo- and radio-therapy, although in many cases the therapy fails and the disease progression resumes. New treatment approaches are needed.Aims: The goal of this pilot study was to examine safety and efficacy of oncolytic Sendai virus therapy administered to canine patients with cutaneous or subcutaneous mastocytomas.Materials and Method… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
13
0
3

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(16 citation statements)
references
References 83 publications
0
13
0
3
Order By: Relevance
“…Four dogs with either primary or recurrent tumors achieved complete responses, three of them long-lasting. The remaining two achieved stable disease [ 79 ]. These results justify further clinical studies of SV for the treatment of canine cutaneous/subcutaneous mastocytoma.…”
Section: Oncolytic Viruses For Canine Cancer Treatmentmentioning
confidence: 99%
See 2 more Smart Citations
“…Four dogs with either primary or recurrent tumors achieved complete responses, three of them long-lasting. The remaining two achieved stable disease [ 79 ]. These results justify further clinical studies of SV for the treatment of canine cutaneous/subcutaneous mastocytoma.…”
Section: Oncolytic Viruses For Canine Cancer Treatmentmentioning
confidence: 99%
“…These results justify further clinical studies of SV for the treatment of canine cutaneous/subcutaneous mastocytoma. Small lesions showed a better response to SV therapy [ 79 ]; yet, in routine practice, these lesions are usually resected. [ 80 ].…”
Section: Oncolytic Viruses For Canine Cancer Treatmentmentioning
confidence: 99%
See 1 more Smart Citation
“…Oncolytic viruses are gaining ground as an alternative therapy in veterinary oncology. Several studies involving adenovirus, myxoma virus, Sendai virus, reovirus and vesicular stomatitis virus have been conducted in dogs and cats [28][29][30][31][32][33][34][35][36]. Promising results have been reported by intratumoral or intravenous routes on dogs and cats with cancer.…”
Section: Discussionmentioning
confidence: 99%
“…Oncolytic viruses are gaining ground as an alternative therapy for treating cancer in veterinary oncology. Indeed, several studies involving adenovirus, myxoma virus, sendai virus, reovirus and vesicular stomatitis virus have been conducted in dogs and cats [28][29][30][31][32][33][34][35][36]. Promising results have been reported by intratumoral or intravenous routes on dogs and cats bearing cancers.…”
Section: Discussionmentioning
confidence: 99%